A detailed history of Quaker Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Quaker Wealth Management, LLC holds 4,758 shares of BMY stock, worth $257,788. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,758
Previous 4,586 3.75%
Holding current value
$257,788
Previous $235,000 9.79%
% of portfolio
0.1%
Previous 0.11%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$47.98 - $54.4 $8,252 - $9,356
172 Added 3.75%
4,758 $258,000
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $64,866 - $77,403
-1,338 Reduced 22.59%
4,586 $235,000
Q3 2023

Oct 19, 2023

BUY
$57.89 - $64.73 $110,512 - $123,569
1,909 Added 47.55%
5,924 $343,000
Q2 2023

Aug 03, 2023

BUY
$63.71 - $70.74 $70,654 - $78,450
1,109 Added 38.16%
4,015 $256,000
Q1 2023

Apr 25, 2023

SELL
$65.71 - $74.53 $591 - $670
-9 Reduced 0.31%
2,906 $201,000
Q4 2022

Feb 02, 2023

BUY
$68.48 - $81.09 $479 - $567
7 Added 0.24%
2,915 $210,000
Q3 2022

Oct 26, 2022

SELL
$0.13 - $76.84 $24 - $14,753
-192 Reduced 6.19%
2,908 $207,000
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $508 - $559
7 Added 0.23%
3,100 $239,000
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $85,580 - $102,618
-1,392 Reduced 31.04%
3,093 $226,000
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $240,530 - $280,402
4,485 New
4,485 $280,000
Q1 2020

Apr 14, 2020

SELL
$46.4 - $67.43 $144,768 - $210,381
-3,120 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $153,535 - $200,272
3,120 New
3,120 $200,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Quaker Wealth Management, LLC Portfolio

Follow Quaker Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quaker Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quaker Wealth Management, LLC with notifications on news.